{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:17:55Z","timestamp":1793143075838,"version":"4.5.0"},"reference-count":35,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T00:00:00Z","timestamp":1532390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute respiratory failure is a leading cause of intensive care unit admission in patients with hematological malignancies; it carries a mortality rate exceeding 50%. Venovenous extracorporeal membrane oxygenation use in patients with acute hematologic malignancies concurrently receiving induction chemotherapy is not well studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 44-year-old male developed acute respiratory distress syndrome in the setting of newly diagnosed acute myelogenous leukemia. He underwent successful induction chemotherapy while on venovenous extracorporeal membrane oxygenation. His course was complicated by a devastating subarachnoid hemorrhage. Life support modalities were discontinued in accordance to the wishes of the family.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There is a lack of data to guide use of induction chemotherapy in patients with acute hematologic malignancies requiring venovenous extracorporeal membrane oxygenation, particularly with regard to dosing, safety, and efficacy of chemotherapeutic agents. This case highlights a potential role of venovenous extracorporeal membrane oxygenation in select young acute myelogenous leukemia patients who might benefit from this intervention and warrants further research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1078155218788735","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T02:25:48Z","timestamp":1532485548000},"page":"1491-1496","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Initiation of venovenous extracorporeal membrane oxygenation in a patient receiving induction chemotherapy for acute myelogenous leukemia"],"prefix":"10.1177","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1123-1704","authenticated-orcid":false,"given":"Sameer K","family":"Avasarala","sequence":"first","affiliation":[{"name":"Respiratory Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad R","family":"Qureshi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, MedStar Union Memorial Hospital, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Waldron","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudipto","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita J","family":"Reddy","sequence":"additional","affiliation":[{"name":"Respiratory Institute, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,7,24]]},"reference":[{"key":"bibr1-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2004.1.98"},{"key":"bibr2-1078155218788735","unstructured":"Sekeres MA. Acute Myeloid Leukemia, http:\/\/www.clevelandclinicmeded.com\/medicalpubs\/diseasemanagement\/hematology-oncology\/acute-myelogenous-leukemia\/ (2017, accessed 27 September 2017)."},{"key":"bibr3-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2004.02.006"},{"key":"bibr4-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0291"},{"key":"bibr5-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3027656"},{"key":"bibr6-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-516"},{"key":"bibr7-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1186\/cc13701"},{"key":"bibr8-1078155218788735","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.02.23"},{"key":"bibr9-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-016-2734-7"},{"key":"bibr10-1078155218788735","unstructured":"Health NIo. Cancer Stat Facts: Acute Myeloid Leukemia (AML), https:\/\/seer.cancer.gov\/statfacts\/html\/amyl.html (accessed 05 October 2017)."},{"key":"bibr11-1078155218788735","doi-asserted-by":"crossref","unstructured":"Vadde R and Pastores SM. Management of acute respiratory failure in patients with hematological malignancy.\n                      J Intensive Care Med\n                      2015; 31: 627\u2013641.","DOI":"10.1177\/0885066615601046"},{"key":"bibr12-1078155218788735","first-page":"640528","volume":"2015","author":"Huang M","year":"2015","journal-title":"Case Rep Hematol"},{"key":"bibr13-1078155218788735","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.887709"},{"key":"bibr14-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1979.03300200023016"},{"key":"bibr15-1078155218788735","doi-asserted-by":"publisher","DOI":"10.5492\/wjccm.v2.i4.29"},{"key":"bibr16-1078155218788735","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.83a.15021"},{"key":"bibr17-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1097\/MAT.0000000000000154"},{"key":"bibr18-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1186\/cc12782"},{"key":"bibr19-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2010.01.018"},{"key":"bibr20-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1310-9"},{"key":"bibr21-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201311-2023OC"},{"key":"bibr22-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-015-0082-7"},{"key":"bibr23-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1097\/LBR.0000000000000385"},{"key":"bibr24-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0891-z"},{"key":"bibr25-1078155218788735","unstructured":"Cytarabine [Package Insert]. New York, NY 2011."},{"key":"bibr26-1078155218788735","unstructured":"Idarubicin [Package Insert]. New York, NY 2006."},{"key":"bibr27-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1177\/106002809202600311"},{"key":"bibr28-1078155218788735","unstructured":"Perry M.\n                      The Chemotherapy Source Book\n                      , 5th ed. Lippincott Williams & Wilkins. Philadelphia, PA 2008."},{"key":"bibr29-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-010-1373-2"},{"key":"bibr30-1078155218788735","unstructured":"Aronoff GR BW and Berns JS.\n                      Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children\n                      . 22: American College of Physicians. Philadelphia, PA 2007."},{"key":"bibr31-1078155218788735","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.890798"},{"key":"bibr32-1078155218788735","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood.V78.10.2520.2520","volume":"78","author":"Dillman RO","year":"1991","journal-title":"Blood"},{"key":"bibr33-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904544"},{"key":"bibr34-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.2.313.313"},{"key":"bibr35-1078155218788735","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.72.8618"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155218788735","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1078155218788735","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155218788735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:19:18Z","timestamp":1777688358000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1078155218788735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,24]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1177\/1078155218788735"],"URL":"https:\/\/doi.org\/10.1177\/1078155218788735","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,24]]}}}